Four Core Genotypes mouse model

Last updated
The Four Core Genotypes mouse model produces four types of offspring. Mice with ovaries (green) can have XX or XY sex chromosomes. Mice with testes (orange) can have XX or XY sex chromosomes. A difference in phenotype in mice with different sex chromosomes (XX vs. XY) shows a sex chromosome effect. A difference in phenotype in mice with different type of gonad shows the effects of gonadal hormones. Revised figure.jpg
The Four Core Genotypes mouse model produces four types of offspring. Mice with ovaries (green) can have XX or XY sex chromosomes. Mice with testes (orange) can have XX or XY sex chromosomes. A difference in phenotype in mice with different sex chromosomes (XX vs. XY) shows a sex chromosome effect. A difference in phenotype in mice with different type of gonad shows the effects of gonadal hormones.

Four Core Genotypes (FCG) mice are laboratory mice produced by genetic engineering that allow biomedical researchers to determine if a sex difference in phenotype is caused by effects of gonadal hormones or sex chromosome genes. [1] [2] The four genotypes include XX and XY mice with ovaries, and XX and XY mice with testes. The comparison of XX and XY mice with the same type of gonad reveals sex differences in phenotypes that are caused by sex chromosome genes. The comparison of mice with different gonads but the same sex chromosomes reveals sex differences in phenotypes that are caused by gonadal hormones.

Contents

Development

The FCG model was created by Paul Burgoyne [3] and Robin Lovell-Badge at the National Institute for Medical Research, London (now Francis Crick Institute). The model involves deleting the testis-determining gene Sry from the Y chromosome, and inserting Sry onto chromosome 3. Therefore the sex chromosomes no longer determine the type of gonad, so that XX and XY mice can have the same type of gonad and gonadal hormones.

Significance

The FCG model has been used to discover that the XX and XY animals respond differently in models of human physiology and disease, including autoimmunity, metabolism, cardiovascular disease, cancer, Alzheimer’s disease, and neural and behavioral processes. [2] [4] [5] [6] [7] These findings imply that some sex chromosome genes may protect from disease, rationalizing the search for therapies that enhance such protective factors. [8]

Related Research Articles

<span class="mw-page-title-main">XY sex-determination system</span> Method of determining sex

The XY sex-determination system is a sex-determination system used to classify many mammals, including humans, some insects (Drosophila), some snakes, some fish (guppies), and some plants. In this system, the sex of an individual is determined by a pair of sex chromosomes. Females have two of the same kind of sex chromosome (XX), and are called the homogametic sex. Males have two different kinds of sex chromosomes (XY), and are called the heterogametic sex.

<span class="mw-page-title-main">Sex-determination system</span> Biological system that determines the development of an organisms sex

A sex-determination system is a biological system that determines the development of sexual characteristics in an organism. Most organisms that create their offspring using sexual reproduction have two common sexes and a few less common intersex variations.

<span class="mw-page-title-main">XY gonadal dysgenesis</span> Medical condition

XY gonadal dysgenesis, also known as Swyer syndrome, is a type of defect hypogonadism in a person whose karyotype is 46,XY. Though they typically have normal vulvas, the person has underdeveloped gonads, fibrous tissue termed "streak gonads", and if left untreated, will not experience puberty. The cause is a lack or inactivation of an SRY gene which is responsible for sexual differentiation. Pregnancy is often possible in Swyer syndrome with assisted reproductive technology. The phenotype is usually similar to Turner syndrome (45,X0) due to a lack of X inactivation. The typical medical treatment is hormone replacement therapy. The syndrome was named after Gerald Swyer, an endocrinologist based in London.

<span class="mw-page-title-main">Sexual differentiation</span> Embryonic development of sex differences

Sexual differentiation is the process of development of the sex differences between males and females from an undifferentiated zygote. Sex determination is often distinct from sex differentiation; sex determination is the designation for the development stage towards either male or female, while sex differentiation is the pathway towards the development of the phenotype.

<span class="mw-page-title-main">Sex-determining region Y protein</span> Protein that initiates male sex determination in therian mammals

Sex-determining region Y protein (SRY), or testis-determining factor (TDF), is a DNA-binding protein encoded by the SRY gene that is responsible for the initiation of male sex determination in therian mammals. SRY is an intronless sex-determining gene on the Y chromosome. Mutations in this gene lead to a range of disorders of sex development with varying effects on an individual's phenotype and genotype.

<span class="mw-page-title-main">XX male syndrome</span> Congenital condition where an individual with a 46,XX karyotype is male

XX male syndrome, also known as de la Chapelle syndrome, is a rare congenital intersex condition in which an individual with a 46,XX karyotype develops a male phenotype. Synonyms include 46,XX testicular difference of sex development, 46,XX sex reversal, nonsyndromic 46,XX testicular DSD, and XX sex reversal.

<span class="mw-page-title-main">Sex cords</span> Structures that develop from the genital ridges that further differentiate based on an embryos sex

Sex cords are embryonic structures which eventually will give rise (differentiate) to the adult gonads. They are formed from the genital ridges - which will develop into the gonads - in the first 2 months of gestation which depending on the sex of the embryo will give rise to male or female sex cords. These epithelial cells penetrate and invade the underlying mesenchyme to form the primitive sex cords. This occurs shortly before and during the arrival of the primordial germ cells (PGCs) to the paired genital ridges. If there is a Y chromosome present, testicular cords will develop via the Sry gene : repressing the female sex cord genes and activating the male. If there is no Y chromosome present the opposite will occur, developing ovarian cords. Prior to giving rise to sex cords, both XX and XY embryos have Müllerian ducts and Wolffian ducts. One of these structures will be repressed to induce the other to further differentiate into the external genitalia.

<span class="mw-page-title-main">Genital ridge</span>

The genital ridge is the precursor to the gonads. The genital ridge initially consists mainly of mesenchyme and cells of underlying mesonephric origin. Once oogonia enter this area they attempt to associate with these somatic cells. Development proceeds and the oogonia become fully surrounded by a layer of cells.

XX gonadal dysgenesis is a type of female hypogonadism in which the ovaries do not function to induce puberty in an otherwise normal girl whose karyotype is found to be 46,XX. With nonfunctional streak ovaries, she is low in estrogen levels (hypoestrogenic) and has high levels of FSH and LH. Estrogen and progesterone therapy is usually then commenced. Some cases are considered a severe version of premature ovarian failure where the ovaries fail before puberty.

<span class="mw-page-title-main">Gonadal dysgenesis</span> Congenital disorder of the reproductive system

Gonadal dysgenesis is classified as any congenital developmental disorder of the reproductive system in humans. It is atypical development of gonads in an embryo. One type of gonadal dysgenesis is the development of functionless, fibrous tissue, termed streak gonads, instead of reproductive tissue. Streak gonads are a form of aplasia, resulting in hormonal failure that manifests as sexual infantism and infertility, with no initiation of puberty and secondary sex characteristics.

<span class="mw-page-title-main">Sexual differentiation in humans</span> Process of development of sex differences in humans

Sexual differentiation in humans is the process of development of sex differences in humans. It is defined as the development of phenotypic structures consequent to the action of hormones produced following gonadal determination. Sexual differentiation includes development of different genitalia and the internal genital tracts and body hair plays a role in sex identification.

<span class="mw-page-title-main">Disorders of sex development</span> Medical conditions involving the development of the reproductive system

Disorders of sex development (DSDs), also known as variations in sex characteristics (VSC), are congenital conditions affecting the reproductive system, in which development of chromosomal, gonadal, or anatomical sex is atypical.

<span class="mw-page-title-main">Steroidogenic factor 1</span> Protein-coding gene in humans

The steroidogenic factor 1 (SF-1) protein is a transcription factor involved in sex determination by controlling the activity of genes related to the reproductive glands or gonads and adrenal glands. This protein is encoded by the NR5A1 gene, a member of the nuclear receptor subfamily, located on the long arm of chromosome 9 at position 33.3. It was originally identified as a regulator of genes encoding cytochrome P450 steroid hydroxylases, however, further roles in endocrine function have since been discovered.

<span class="mw-page-title-main">SOX9</span> Transcription factor gene of the SOX family

Transcription factor SOX-9 is a protein that in humans is encoded by the SOX9 gene.

<span class="mw-page-title-main">SOX3</span> Protein-coding gene in the species Homo sapiens

Transcription factor SOX-3 is a protein that in humans is encoded by the SOX3 gene. This gene encodes a member of the SOX family of transcription factors involved in the regulation of embryonic brain development and in determination of cell fate. The encoded protein acts as a transcriptional activator.

46,XX/46,XY is a chimeric genetic condition characterized by the presence of some cells that express a 46,XX karyotype and some cells that express a 46,XY karyotype in a single human being. The cause of the condition lies in utero with the aggregation of two distinct blastocysts or zygotes into a single embryo, which subsequently leads to the development of a single individual with two distinct cell lines, instead of a pair of fraternal twins. 46,XX/46,XY chimeras are the result of the merging of two non-identical twins. This is not to be confused with mosaicism or hybridism, neither of which are chimeric conditions. Since individuals with the condition have two cell lines of the opposite sex, it can also be considered an intersex condition.

Sex reversal is a biological process whereby the pathway directed towards the already determined-sex fate is flipped towards the opposite sex, creating a discordance between the primary sex fate and the sex phenotype expressed. The process of sex reversal occurs during embryonic development or before gonad differentiation. In GSD species, sex reversal means that the sexual phenotype is discordant with the genetic/chromosomal sex. In TSD species, sex reversal means that the temperature/conditions that usually trigger the differentiation towards one sexual phenotype are producing the opposite sexual phenotype.

45,X/46,XY mosaicism, also known as X0/XY mosaicism and mixed gonadal dysgenesis, is a mutation of sex development in humans associated with sex chromosome aneuploidy and mosaicism of the Y chromosome. It is a fairly rare chromosomal disorder at birth, with an estimated incidence rate of about 1 in 15,000 live births. Mosaic loss of the Y chromosome in previously non-mosaic men grows increasingly common with age.

Sexual anomalies, also known as sexual abnormalities, are a set of clinical conditions due to chromosomal, gonadal and/or genitalia variation. Individuals with congenital (inborn) discrepancy between sex chromosome, gonadal, and their internal and external genitalia are categorised as individuals with a disorder of sex development (DSD). Afterwards, if the family or individual wishes, they can partake in different management and treatment options for their conditions.

<span class="mw-page-title-main">Arthur P. Arnold</span> American biologist

Arthur Palmer Arnold is an American biologist who specializes in sex differences in physiology and disease, genetics, neuroendocrinology, and behavior. He is Distinguished Professor of Integrative Biology & Physiology at the University of California, Los Angeles (UCLA). His research has included the discovery of large structural sex differences in the central nervous system, and he studies of how gonadal hormones and sex chromosome genes cause sex differences in numerous tissues. His research program has suggested revisions to concepts of mammalian sexual differentiation and forms a foundation for understanding sex difference in disease. Arnold was born in Philadelphia.

References

  1. Arnold, AP; Chen, X (2009). "What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues?". Front. Neuroendocrinol. 30 (1): 1–9. doi:10.1016/j.yfrne.2008.11.001. PMC   3282561 . PMID   19028515.
  2. 1 2 Arnold, AP (2020). "Four Core Genotypes and XY* mouse models: Update on impact on SABV research". Neurosci Biobehav Rev. 119: 1–8. doi:10.1016/j.neubiorev.2020.09.021. PMC   7736196 . PMID   32980399.
  3. Turner, JMA; Mahadevaiah, SK; Arnold, AP; Lovell-Badge, R. (2020). "Paul S. Burgoyne (1946-2020)". Development. 147 (20). doi: 10.1242/dev.197467 . PMID   33109617. S2CID   225100609.
  4. Arnold, AP (2019). "Rethinking sex determination of non-gonadal tissues". Sex Determination in Vertebrates. Current Topics in Developmental Biology. Vol. 134. pp. 289–315. doi:10.1016/bs.ctdb.2019.01.003. ISBN   9780128115442. PMC   7485614 . PMID   30999979.
  5. Voskuhl, RR. (2020). "The effect of sex on multiple sclerosis risk and disease progression". Mult Scler. 26 (5): 554–60. doi:10.1177/1352458519892491. PMC   7160019 . PMID   31965884.
  6. Zore, T; Palafox, M; Reue, K (2018). "Sex differences in obesity, lipid metabolism, and inflammation-A role for the sex chromosomes?". Mol Metab. 15: 35–44. doi:10.1016/j.molmet.2018.04.003. PMC   6066740 . PMID   29706320.
  7. Reue, K; Wiese, CB (2022). "Illuminating the Mechanisms Underlying Sex Differences in Cardiovascular Disease". Circ. Res. 130 (12): 1747–62. doi:10.1161/CIRCRESAHA.122.320259. PMC   9202078 . PMID   35679362.
  8. Arnold, AP (2022). "X chromosome agents of sexual differentiation". Nat Rev Endocrinol. 18 (9): 574–583. doi:10.1038/s41574-022-00697-0. PMC   9901281 . PMID   35705742.